Chris Evans readies first investments from new biotech fund; Natanson named Brainstorm CEO;

 @FierceBiotech: Keryx shares soar on upbeat PhIII results for CKD drug Zerenex. Article | Follow @FierceBiotech

@JohnCFierce: New bidness model: VCs launch another biotech with late-stage R&D model for Big Pharma--(think SFJ). More | Follow @JohnCFierce

@RyanMFierce: FDA called out in study of smartphone apps for melanoma. Report | Follow @RyanMFierce

> The £100 million Welsh Life Sciences Fund set up by Sir Chris Evans is preparing to unveil its first slate of investments. "It's a ten year fund and we will not be doing everything in the first year, but we have already done a lot of the ground work around various companies in Wales," Evans told WalesOnline. Story

> BrainStorm Cell Therapeutics named Alon Natanson as its new CEO. Release

> French regulators are on Bayer's trail again. The ANSM agency has launched a probe into four deaths linked to the acne drug Diane-35, also used as a contraceptive. Story

Pharma News

@FiercePharma: Another Bayer drug gets the eye from French regulators: Acne drug/BCP Diane-35 linked to 4 deaths, ANSM says. More | Follow @FiercePharma

 @AlisonBFierce: GSK formed a joint venture in India to produce a 6-in-1 vaccine that will immunize children in developing countries. News | Follow @AlisonBFierce

> France launches safety probe into another Bayer drug. News

> Takeda Pharmaceutical aims to backfill Actos sales with new diabetes franchise. Story

Medical Device News

 @FierceMedDev: UNC team identifies Dx to spot worsening macular degeneration. News | Follow @FierceMedDev

 @MarkHFierce: The Netherlands' Medisse nailed down a $3.5M US Series B to fund development of a bioresorbable material for implants. Release | Follow @MarkHFierce

 @DamianFierce: That rumored Quintiles IPO may finally be around the corner, anon. sources tell Reuters, Bloomberg. News | Follow @DamianFierce

> Medisse raises $3.5M for new med device biomaterial. Article

> Given Imaging is no longer selling itself, but an EU investor wants a piece. More

Biotech IT News

> FDA called out in study of smartphone apps for melanoma. Article

> Big Data analysis takes on childhood brain cancer. Story

> Hopkins mines Twitter for real flu cases in real time. More

> NIH supports Parkinson's research with online collaboration. Item

CRO News

> Is Quintiles finally going public? Article

> Covance soars on 60% income growth in Q4. Report

> GVK teams up with Endo on early-stage pain drug. Story

> Indian Supreme Court wants answers on clinical trials. More

And Finally… Researchers at Duke say that early-stage breast cancer patients treated with lumpectomy plus radiation may have a better chance of survival compared with those who underwent mastectomy. Release


Suggested Articles

Eli Lilly is combining the oncology team at Lilly Research Laboratories with Loxo Oncology and putting a trio of Loxo execs at the helm.

The failure of SAGE-217 to beat placebo wiped more than 50% off Sage’s share price as investors digested the implications of the data.

The data tee Aurinia up to file for FDA approval next year and go on to address a major unmet medical need.